We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Increases Yet Falls Behind Market: What Investors Need to Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed the latest trading day at $10.98, indicating a +0.46% change from the previous session's end. This move lagged the S&P 500's daily gain of 1.47%. On the other hand, the Dow registered a gain of 1.39%, and the technology-centric Nasdaq increased by 1.51%.
Heading into today, shares of the largest U.S. drugstore chain had lost 1.18% over the past month, lagging the Retail-Wholesale sector's gain of 0.12% and the S&P 500's loss of 0.47% in that time.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. It is anticipated that the company will report an EPS of $0.34, marking a 46.03% fall compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $36.66 billion, up 0.85% from the year-ago period.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $1.66 per share and revenue of $151.49 billion. These results would represent year-over-year changes of -42.36% and +2.59%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Walgreens Boots Alliance. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.25% higher. Walgreens Boots Alliance is currently a Zacks Rank #3 (Hold).
With respect to valuation, Walgreens Boots Alliance is currently being traded at a Forward P/E ratio of 6.58. This indicates a premium in contrast to its industry's Forward P/E of 5.03.
Meanwhile, WBA's PEG ratio is currently 1.32. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Retail - Pharmacies and Drug Stores industry was having an average PEG ratio of 0.76.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 3, which puts it in the top 2% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Increases Yet Falls Behind Market: What Investors Need to Know
Walgreens Boots Alliance (WBA - Free Report) closed the latest trading day at $10.98, indicating a +0.46% change from the previous session's end. This move lagged the S&P 500's daily gain of 1.47%. On the other hand, the Dow registered a gain of 1.39%, and the technology-centric Nasdaq increased by 1.51%.
Heading into today, shares of the largest U.S. drugstore chain had lost 1.18% over the past month, lagging the Retail-Wholesale sector's gain of 0.12% and the S&P 500's loss of 0.47% in that time.
The investment community will be paying close attention to the earnings performance of Walgreens Boots Alliance in its upcoming release. It is anticipated that the company will report an EPS of $0.34, marking a 46.03% fall compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $36.66 billion, up 0.85% from the year-ago period.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $1.66 per share and revenue of $151.49 billion. These results would represent year-over-year changes of -42.36% and +2.59%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Walgreens Boots Alliance. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.25% higher. Walgreens Boots Alliance is currently a Zacks Rank #3 (Hold).
With respect to valuation, Walgreens Boots Alliance is currently being traded at a Forward P/E ratio of 6.58. This indicates a premium in contrast to its industry's Forward P/E of 5.03.
Meanwhile, WBA's PEG ratio is currently 1.32. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Retail - Pharmacies and Drug Stores industry was having an average PEG ratio of 0.76.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 3, which puts it in the top 2% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.